Cigarette smoking patterns preceding primary Sjögren's syndrome.
Autoantibodies
Sjogren’s Syndrome
Smoking
Journal
RMD open
ISSN: 2056-5933
Titre abrégé: RMD Open
Pays: England
ID NLM: 101662038
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
17
07
2020
revised:
20
08
2020
accepted:
09
09
2020
entrez:
30
9
2020
pubmed:
1
10
2020
medline:
1
9
2021
Statut:
ppublish
Résumé
Cigarette smoking is a well-established risk factor for several autoimmune diseases, but its role in primary Sjögren's syndrome (pSS) remains unclear. Here, we investigated the association between cigarette smoking and subsequent development of pSS. Information on smoking habits was collected from lifestyle habit questionnaires of patients with pSS (n=815) and a matched control group (n=4425) for a case-control study. Differences in smoking exposure were analysed by conditional logistic regression. Potential interactions between smoking and risk-associated human leucocyte antigens (HLA) were assessed by multivariate regression. The fraction of patients with pSS having ever smoked prior to diagnosis was lower than in controls (OR 0.67, 95% CI 0.55 to 0.81). Current smoking at diagnosis was also less prevalent in cases (OR 0.37, 95% CI 0.26 to 0.53). However, period prevalence of smoking during early adulthood was not statistically different from controls (OR 0.89, 95% CI 0.66 to 1.22) but markedly decreased over time. This was partly due to patients being more prone to stop smoking, starting already 30 years prior to diagnosis (OR 2.01, 95% CI 1.22 to 3.30). Smoking patterns were also stratified by autoantibody status, yielding similar estimates. No interaction effects between HLA-DRB1 haplotypes and smoking were observed. The observed smoking patterns indicate that individuals who develop pSS smoke equally much as the general population during early life but are then more prone to stop. The data can be interpreted as smoking conferring protective effects, or reflecting early symptoms of pSS that affect smoking habits, emphasising the slow, progressive development of the disease.
Sections du résumé
BACKGROUND
BACKGROUND
Cigarette smoking is a well-established risk factor for several autoimmune diseases, but its role in primary Sjögren's syndrome (pSS) remains unclear. Here, we investigated the association between cigarette smoking and subsequent development of pSS.
METHODS
METHODS
Information on smoking habits was collected from lifestyle habit questionnaires of patients with pSS (n=815) and a matched control group (n=4425) for a case-control study. Differences in smoking exposure were analysed by conditional logistic regression. Potential interactions between smoking and risk-associated human leucocyte antigens (HLA) were assessed by multivariate regression.
RESULTS
RESULTS
The fraction of patients with pSS having ever smoked prior to diagnosis was lower than in controls (OR 0.67, 95% CI 0.55 to 0.81). Current smoking at diagnosis was also less prevalent in cases (OR 0.37, 95% CI 0.26 to 0.53). However, period prevalence of smoking during early adulthood was not statistically different from controls (OR 0.89, 95% CI 0.66 to 1.22) but markedly decreased over time. This was partly due to patients being more prone to stop smoking, starting already 30 years prior to diagnosis (OR 2.01, 95% CI 1.22 to 3.30). Smoking patterns were also stratified by autoantibody status, yielding similar estimates. No interaction effects between HLA-DRB1 haplotypes and smoking were observed.
CONCLUSION
CONCLUSIONS
The observed smoking patterns indicate that individuals who develop pSS smoke equally much as the general population during early life but are then more prone to stop. The data can be interpreted as smoking conferring protective effects, or reflecting early symptoms of pSS that affect smoking habits, emphasising the slow, progressive development of the disease.
Identifiants
pubmed: 32994363
pii: rmdopen-2020-001402
doi: 10.1136/rmdopen-2020-001402
pmc: PMC7547543
pii:
doi:
Substances chimiques
Autoantibodies
0
Smoke
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Eur J Epidemiol. 2017 Oct;32(10):909-919
pubmed: 28597127
Autoimmun Rev. 2012 Feb;11(4):281-7
pubmed: 22001416
Br J Rheumatol. 1993 Oct;32(10):903-7
pubmed: 8402000
Nat Genet. 2013 Nov;45(11):1284-92
pubmed: 24097067
Arthritis Res Ther. 2017 Mar 7;19(1):50
pubmed: 28270185
Ann Rheum Dis. 2003 Sep;62(9):835-41
pubmed: 12922955
N Engl J Med. 2018 Mar 08;378(10):931-939
pubmed: 29514034
Ann Rheum Dis. 2002 Jun;61(6):554-8
pubmed: 12006334
Scand J Rheumatol. 2015;44(2):135-42
pubmed: 25222653
Rheumatology (Oxford). 2020 Aug 21;:
pubmed: 32889544
J Intern Med. 2020 May;287(5):475-492
pubmed: 32107824
Nat Rev Neurol. 2017 Jan;13(1):25-36
pubmed: 27934854
J Intern Med. 2020 May;287(5):514-533
pubmed: 32176395
Ann Rheum Dis. 2012 Jun;71(6):981-8
pubmed: 22294627
Ann Rheum Dis. 2000 Jan;59(1):54-60
pubmed: 10627428
Clin Exp Rheumatol. 2007 May-Jun;25(3):378-84
pubmed: 17631733
Ann Rheum Dis. 2016 Feb;75(2):348-55
pubmed: 25433020
Eur J Epidemiol. 2018 Apr;33(4):415-423
pubmed: 29387991
Arthritis Rheum. 2006 Jan;54(1):38-46
pubmed: 16385494
Mod Rheumatol. 2011 Dec;21(6):602-7
pubmed: 21445716
JAMA. 2013 Nov 6;310(17):1854-5
pubmed: 24193084
Lupus. 2014 May;23(6):537-44
pubmed: 24763538
Arthritis Rheumatol. 2015 Sep;67(9):2427-36
pubmed: 26109563
Curr Opin Rheumatol. 2013 Jul;25(4):480-7
pubmed: 23719365
Arthritis Rheum. 2003 Aug;48(8):2240-5
pubmed: 12905478
Rheumatology (Oxford). 2020 Jul 1;59(7):1651-1661
pubmed: 31665501
Immunol Today. 1999 May;20(5):234-40
pubmed: 10322303
Brain. 2011 Mar;134(Pt 3):653-64
pubmed: 21303861
Lancet. 2013 Aug 31;382(9894):819-31
pubmed: 23993191
Curr Opin Rheumatol. 2015 Sep;27(5):468-75
pubmed: 26108063
Semin Arthritis Rheum. 2018 Feb;47(4):538-544
pubmed: 28755788
Arthritis Rheumatol. 2015 Jul;67(7):1904-12
pubmed: 25940005
J Rheumatol. 1986 Oct;13(5):899-902
pubmed: 3820198
Arthritis Rheum. 2004 Oct;50(10):3085-92
pubmed: 15476204
PLoS Comput Biol. 2013;9(2):e1002877
pubmed: 23459081
Arthritis Care Res (Hoboken). 2014 May;66(5):757-64
pubmed: 24877201
J Intern Med. 2019 Jun;285(6):670-680
pubmed: 30892751
Scand J Rheumatol. 2000;29(1):13-9
pubmed: 10722253
J Intern Med. 2019 Oct;286(4):458-468
pubmed: 31127862
PLoS One. 2017 Feb 6;12(2):e0170249
pubmed: 28166540